Mark Krause

Mark Krause has a solid work experience history in the biopharmaceutical industry. Mark served as the Senior Vice President of Operations at Evolve Biologics starting in January 2021. Prior to that, they held the position of Head of Plasma Proteins at the same company from March 2018 to January 2021. Before joining Evolve Biologics, they worked at Therapure Biopharma Inc as the Head of Plasma Proteins from February 2011 to March 2018. Mark also has experience at Valeant Pharmaceuticals (formerly Biovail) as the Director of Financial Planning and Analysis, where they worked from June 2004 to November 2010.

Mark Krause completed their MBA with a Biotech Stream at the Ivey Business School at Western University from 2002 to 2004. Prior to that, they earned their BSc in Science - Biology from The University of British Columbia from 1993 to 1997. Mark also holds a certification as a CPA from the Chartered Professional Accountants of Canada (CPA Canada), although the specific timeframe of obtaining this certification is not provided.